MTAP-null Non-Small-Cell Lung Cancer
Oncology·MeSH: Neoplasms
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| anvumetostat | AMGEN INC (AMGN) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| ide397 | AMGEN INC (AMGN) |
Compare drugs
Frequently asked questions
How many drugs are in development for MTAP-null Non-Small-Cell Lung Cancer?
BioSniper tracks 2 drugs in development for MTAP-null Non-Small-Cell Lung Cancer across 1 company.
How many clinical trials target MTAP-null Non-Small-Cell Lung Cancer?
There are 1 clinical trial targeting MTAP-null Non-Small-Cell Lung Cancer tracked by BioSniper.
Deep-dive into MTAP-null Non-Small-Cell Lung Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis